The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Zofran Birth Defects Will Lead to a Rise in Mass Tort Litigation

Posted on October 30, 2015 by Eleanor Smith

belly of pregnant woman and vitamin pills in the hand

The rise of mass tort litigation continues with a focus on Zofran, an anti-nausea drug. The FDA approved Zofran for women undergoing chemotherapy. Later, Zofran was illegally marketed to pregnant women for the off-label use of treating morning sickness, which caused serious birth defects.

Birth Defects

Several years ago, GlaxoSmithKline – the manufacturer of Zofran – reached a $3 billion settlement with the Justice Department for the fraudulent marketing. A multidistrict litigation (MDL) docket was subsequently created in Philadelphia, and the first cases were filed in 2014.

Zofran has been on the market since 1991, and evidence shows approximately 30,000 children were born with birth defects because of the drug’s off-label use.

A mass tort is ordinarily a product liability case where hundreds of plaintiffs file suit collectively against a pharmaceutical company. These cases are typically collected into one of 300 federal MDL dockets.

The average settlement value for a single plaintiff is $600,000. This appears to be the cost of doing business to GlaxoSmithKline. The types of birth defects caused by Zofran are similar to the birth defects caused by Paxil, a drug with a currently high settlement value. Thus, it is safe to assume the settlement value of defects caused by Zofran will be similar, too.

The 2012 GlaxoSmithKline criminal case does not affect the settlement value in civil cases.

See Also: Top 5 Mass Tort Cases for Plaintiff Lawyers Right Now

According to senior consultant and former pharmaceutical executive John Ray, “Zofran is in the early stages of the litigation. We estimate that it will take six years, from this point, for an investment in the Zofran case to pay return on [plaintiff attorneys’] investments.” This is the cost of doing business for mass tort plaintiffs’ attorneys interested in pursuing Zofran litigation.

Deep Pockets

A decision to form the MDL is expected any time. GlaxoSmithKline (GSK), the second-largest pharmaceutical company in the world by revenue, has deep pockets. In fiscal year 2010, GSK generated revenues of £28.4 billion and net earnings of £1.85 billion after taxes.

Products liability lawyers are currently marketing heavily to find mass tort clients. Marketing expert Steve Nober, CEO of the Consumer Attorney Marketing Group, says that Zofran is one of the most advertised mass tort campaigns out there.

In June, 2015, one mother asserted that she started using Zofran to prevent nausea and vomiting in her first trimester of pregnancy. Six months later, she gave birth to a baby girl who was born with “hole in the heart” defects.The little girl needed surgery immediately.  Her heart defects included ventricular septal defect and atrial septal defect.

In addition to deadly heart defects, Zofran has also caused cleft lip and palate in newborns. One anonymous little girl has undergone ten surgeries to correct her cleft lip and palate. Her mother alleged that her birth defect impairs her development and enjoyment of a normal life both at home and at school.

Personal injury lawyers should expand their practices in the area of Zofran mass tort litigation and keep informed of the MDL progress.

Posted in Blog, Class Actions, Consumer Protection, Mass Torts, Personal Injury, Product Liability, Trial Practice

Comments are closed.

News Categories

Subscribe to Blog and VFJ via Email

Enter your email address to subscribe to this blog, the Voice for Justice and receive notifications of new posts by email.

Read about other Top Jury Verdicts

What is Sexual Harassment?

What is Sexual Harassment?

Sexual Harassment Defined: Legally, sexual harassment is a form of sex discrimination that violates Title VII of the [Read More...]
Facebook Pays $650M to Settle a Privacy Dispute

Facebook Pays $650M to Settle a Privacy Dispute

WASHINGTON: A US federal judge has given final approval to Facebook's US$650 million payment to settle a privacy dispute betw[Read More...]
Pharmaceutical Giant Johnson & Johnson is Preparing $3.9B for Talc Settlements

Pharmaceutical Giant Johnson & Johnson is Preparing $3.9B for Talc Settlements

Pharmaceutical giant Johnson & Johnson has set aside $3.9 billion for talc-related litigation, according to a regulatory [Read More...]
Alaska Airlines Will Pay $3.19M Following the Death of a Passenger

Alaska Airlines Will Pay $3.19M Following the Death of a Passenger

Seattle-based Alaska Airlines has been ordered to pay more than $3 million to the family of a passenger of reduced mobility w[Read More...]
No thumbnail available

Keith Givens on the Trial Lawyers Summit and Lanier Trial Academy

https://vimeo.com/515910581 Michelle Swanner, Executive Director of The National Trial Lawyers, interviews Keith Givens[Read More...]

#LegalNews

@@TheNTLtop100

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.